Search clinical trials for: Scleral contact lens with a passive artificial iris with low contrast (<1:5)

Total 40 results

University Ghent

Terminated

Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris (RGPIRIS_PA)

Low Vision

Belgium
CIBA VISION

Completed

Asian Clinical Evaluation of an Investigational Contact Lens for Cosmetic Effect

Cosmetic Appearance

Singapore
CIBA VISION

Completed

The Effect of Masking on Subjective Results During Daily Disposable Contact Lens Studies (ARGON)

Myopia | Hyperopia

Canada
Alcon Research

Completed

Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens

Refractive Error | Presbyopia | Myopia | Ametropia
University of Pennsylvania
Harvard University; Carnegie Mellon University; incentaHEALTH; McKinsey & Company

Completed

University Of Pennsylvania Weight Loss Study

Weight Loss

United States
Johnson & Johnson Vision Care, Inc.

Completed

Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types

Astigmatism

United States
Hanita Lenses

Completed

A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use

Presbyopia

Israel
Alcon Research

Completed

A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers

Refractive Error | Myopia
CIBA VISION

Completed

Evaluation of the Cosmetic Performance of AIR OPTIX® COLORS

Cosmetic Appearance
Alcon Research

Completed

A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS

Myopia
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

Visual Acuity

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Approved Contact Lenses

Visual Acuity

United States
CIBA VISION
University of Waterloo

Completed

Evaluation of the Performance of AIR OPTIX® COLORS

Myopia

Canada
Alcon Research

Completed

Clinical Biocompatibility Evaluation of Contact Lens Coatings

Refractive Errors | Ametropia

United States
Alcon Research

Completed

On-Eye Evaluation of Contact Lens Rotation Marks

Refractive Error
Johnson & Johnson Vision Care, Inc.

Completed

Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light

Visual Acuity

United States
Alcon Research

Completed

Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)

Myopia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population

Visual Acuity

United States
Alcon Research

Completed

Clinical Evaluation of ACUVUE® OASYS® 1-Day and ACUVUE® OASYS®

Refractive Error
Alcon Research

Completed

Clinical Comparison of 4 Daily Disposable Soft Contact Lenses

Refractive Error

United States
Alcon, a Novartis Company

Completed

ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®

Refractive Error

United States
Johnson & Johnson Vision Care, Inc.

Completed

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Refractive Ametropia

United States
Johnson & Johnson Vision Care, Inc.

Completed

Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore

Visual Acuity

United States
Johnson & Johnson Vision Care, Inc.

Not yet recruiting

Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Visual Acuity

United States
Alcon, a Novartis Company

Completed

Clinical Assessment of a HYDRAGLYDE® Regimen

Refractive Errors | Myopia | Hypermetropia

United States, Germany, Canada
Dongyang People's Hospital

Not yet recruiting

Base Curves of Bandage Contact Lenses and Their Effects on Post Trans-PRK Vision and Pain

Myopia

China
Johnson & Johnson Vision Care, Inc.

Completed

The Effects of Contact Lenses With UV/HEV-Filter on Visual Function

Visual Acuity

United States
Vision Service Plan

Completed

Clinical Performance of 59% Hioxifilcon A vs. Marketed Hydrogel Contact Lenses in Habitual Hydrogel Wearers

Refractive Error - Myopia Bilateral

United States
Vision Service Plan

Completed

Comparative Clinical Performance of 59% Hioxifilcon A Contact Lenses vs. Marketed Hydrogel Contact Lenses (DDHyd)

Refractive Error - Myopia Bilateral

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), The ARCHON-1 Trial

Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell Carcinoma

United States
University of California, San Francisco

Completed

Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures

Anesthesia, Local | Eyelid Tumor | Ophthalmology | Eyelid Bump | Eyelid Deformity | Eyelid Abscess | Eyelid Boil | Eyelid Papilloma

United States
National Cancer Institute (NCI)

Recruiting

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Primary Central Nervous System Lymphoma

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Ovarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditions

United States, Puerto Rico
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.

Completed

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin Lymphoma

United States
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany
National Cancer Institute (NCI)

Recruiting

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Down Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic Lymphoma

United States, Puerto Rico, Australia, Canada, New Zealand

Search clinical trials for: Scleral contact lens with a passive artificial iris with low contrast (<1:5)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations